Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pfizer Inc (PFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pfizer Inc 235 EAST 42ND STREET NEW YORK NY 10017 USA

www.pfizer.com P: 212-733-2323 F: 212-573-7851

Description:

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.

Key Statistics

Overview:

Market Capitalization, $K 213,866,704
Shares Outstanding, K 5,947,350
Annual Sales, $ 52,824 M
Annual Net Income, $ 7,215 M
Last Quarter Sales, $ 12,896 M
Last Quarter Net Income, $ 3,073 M
36-Month Beta 1.00
% of Insider Shareholders 0.06%
% of Institutional Shareholders 69.00%

Growth:

1-Year Total Return 5.30%
3-Year Total Return 21.00%
5-Year Total Return 44.71%
5-Year Revenue Growth -21.66%
5-Year Earnings Growth 3.90%
5-Year Dividend Growth 50.00%

Per-Share Information:

Most Recent Earnings 0.67 on 08/01/17
Next Earnings Date 10/31/17
Earnings Per Share ttm 2.44
EPS Growth vs. Prev Qtr -2.90%
EPS Growth vs. Prev Year 4.69%
Annual Dividend Rate, $ 1.28
Annual Dividend Yield 3.56%
Most Recent Dividend 0.32 on 08/02/17
Next Ex-Dividends Date 08/02/17
Dividend Payable Date 09/01/17
Dividend Payout Ratio 50.12
Most Recent Split 3-1 on 07/01/99

PFE Ratios

Ratio
Price/Earnings ttm 14.74
Price/Earnings forward 14.03
Price/Earnings to Growth 2.53
Return on Equity % 12.06
Return on Assets % 8.60
Profit Margin % 13.66
Debt/Equity 0.52
Price/Sales 4.05
Price/Cash Flow 10.64
Price/Book 3.66
Book Value/Share 9.84
Interest Coverage 0.00

PFE Dividends

Date Value
08/02/17 $0.3200
05/10/17 $0.3200
02/01/17 $0.3200
11/08/16 $0.3000
08/03/16 $0.3000
05/11/16 $0.3000
02/03/16 $0.3000
11/04/15 $0.2800
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.